Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jona Lekura"'
Publikováno v:
Journal of the American Pharmacists Association. 61:e26-e38
Background Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer after disease progression. Thus, timely initiation of anticoagulation after diagnosis of a VTE is required to prevent significant sequelae. Direct or
Autor:
Melissa McCarty, Long To, Brittany Lines, Ileana Lopez-Plaza, Jona Lekura, Hassan Nemeh, Zachary R Smith, Victor Coba, Dana Attar
Publikováno v:
The Annals of pharmacotherapy. 56(5)
Background: Heparin exposure and device-related thrombocytopenia complicate the diagnosis of heparin-induced thrombocytopenia (HIT) in patients receiving mechanical circulatory support (MCS). To improve anticoagulation management for patients with ne
Autor:
Katelyn Dulgar, Jona Lekura, Jacqueline Pyle, James Kalus, Marissa Agnello, Lorne Loveland, Jovan Lozo, Nadeen Abdallah, Thomas Senneff, Henry E. Kim, Gillian Grafton, Celeste T. Williams, Long To
Publikováno v:
Journal of the American College of Cardiology. 79:280
Autor:
James S. Kalus, Jona Lekura
Publikováno v:
American Journal of Health-System Pharmacy. 75:1095-1102
Purpose The role of betrixaban in the prevention of venous thromboembolism (VTE) in acutely medically ill patients and its efficacy and safety profiles are reviewed. Summary Acutely medically ill patients have a high risk of developing VTE during hos
Autor:
Dana Attar, Waleed Al-Darzi, Gillian Grafton, James S. Kalus, Jona Lekura, Celeste T. Williams
Publikováno v:
Journal of Cardiac Failure. 26:S129
Introduction ACE-I/ARBs, beta-blockers (BB), and aldosterone antagonists are standard of care for patients with heart failure and reduced ejection fraction (HFrEF). Studies have shown that a pharmacist-managed heart failure (HF) medication titration
Autor:
Long To, Victor Coba, Dana Attar, Melissa McCarty, Jona Lekura, Brittany Lines, Zachary R Smith
Publikováno v:
Journal of the American College of Cardiology. 73:1212
Mechanical circulatory support (MCS) devices provide hemodynamic support in patients with cardiogenic shock or end-stage heart failure. Heparin exposure and device related thrombocytopenia complicate the diagnosis of heparin-induced thrombocytopenia
Autor:
Jona Lekura
Publikováno v:
The Annals of pharmacotherapy. 49(4)
Objective: To review the role of target-specific anticoagulants (TSACs) for the treatment of venous thromboembolism (VTE) and their associated efficacy and safety. Data Sources: Peer-reviewed clinical trials, review articles, and relevant treatment g
Publikováno v:
Journal of Pharmacy Practice. 27:478-480
Purpose: This project explores electronic mail (e-mail) as a potential medium for pharmacists to communicate pharmacotherapy interventions to prescribers. Methods: This retrospective descriptive analysis was conducted at an urban, academic teaching h
Publikováno v:
The Annals of pharmacotherapy. 47(10)
To review statins in the prevention of cardiovascular disease (CVD) events and their associated safety in patients with end-stage renal disease (ESRD).Peer-reviewed clinical trials, review articles, and treatment guidelines were identified from MEDLI
Publikováno v:
Patient Intelligence. :57
Atrial fibrillation (AF) is the most common cardiac arrhythmia. The progressive and chronic nature of this disease leads to heavy utilization of health care resources, with total health care expenditures estimated to be five times greater for patient